News

Press Releases

Asuragen NGS System Streamlines Detection of NSCLC-associated DNA Mutations, Gene Fusions, and RNA Expression Targets in Single Workflow
Asuragen Releases Updated AmplideX® PCR/CE Reporter Software
Asuragen to Present at 2019 ACMG Annual Clinical Genetics Meeting
Asuragen Portfolio Expansion Continues with Launch of AmplideX® PCR/CE SMN1/2 Kit
Asuragen NGS System for Streamlined Detection of RNA Lung Cancer Variants Demonstrates Superior Performance in Multisite Evaluation
Asuragen Announces Launch of AmplideX® PCR/CE HTT Kit
Asuragen Launches Assay to Aid in the Diagnosis of Myotonic Dystrophy Type I (DM1)
Asuragen Announces Health Canada Approval of the QuantideX® qPCR BCR-ABL IS Kit
Asuragen to Present at 2018 Association for Molecular Pathology (AMP) Annual Meeting
New laboratory screening test for fragile X syndrome shortly after birth now ready for pivotal North Carolina Early Check clinical study

About

Back To
Top